How To Enroll In A Study
Step I: Check Potential Study Eligibility
Our offices participate in various clinical research studies; some of which are listed below. If you are interested in a study that you may be eligible for please contact us to schedule an in-person appointment about proceeding to Step II.
​
Step II: Complete A Pre-Screening Appointment
At the scheduled office appointment you will receive additional information on the research study that you are interested in and you will also complete a pre-screening form in-person. This form will help us determine if you are a match to that specific study to participate in.​
​
Step III: Receive A Follow-Up Consultation
After we review the completed form, if you are eligible for the study selected, then the enrollment process will begin, which may require additional information and/or documentation of your medical history from your health care provider.
​COVID-19 Treatment Study - 2023​
​Location: North Site [Coral Gables]
Duration: 90 days upon enrollment with a total 10 visits.
Summary: Covid treatment study to minimize days with symptoms.
Target Population: Nonhospitalized participants who are 18 to 64 years of age who are not at-risk for developing serious disease and have tested positive for COVID-19 in the past 3 days.
Compensation: For time and travel, participants will be paid at each visit.​
​Bacterial Infection Treatment Study - 2023​
​Location: North Site [Coral Gables] and South Site [Homestead]
Duration: Minimum of 8 on-site visits, along with follow-ups via phone
upon enrollment.
Summary: Blood infection research study regarding E. coli and UTIs.
Target Population: Participants who are 60 or older in age who had a Urinary Tract infection in the past 2 years.
Compensation: For time and travel, participants will be paid at each visit.​
​Schizophrenia Symptoms Treatment Study - 2023​
​Location: North Site [Coral Gables]
Duration: Minimum of 12 weeks upon enrollment with 7 on-site visits.
Summary: Schizophrenia research study for individuals who are experiencing symptoms while on treatment with antipsychotics.
Target Population: Participants who are 18 or older in age who have been
diagnosed with schizophrenia for at least 1 year and have a documented history of not responding well to antipsychotic treatment.
Compensation: For time and travel, participants will be paid at each visit.​
